Biotech Values

[DewDiligence]

EXAS—At 90%+ specificity and the sensitivity observed in the DeeP-C study, the test would (IMO) make sense for screening the general (i.e. low-risk) population; however, increasing the specificity without decreasing the sensitivity would require a smarter version of the test.